23 results
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
materials from third-party suppliers and potential exposure to supply chain issues impacting delivery dates, quality, quantity and pricing of raw … perform according to the terms of the agreements between Apexigen and them;
the possible failure of Apexigen’s third-party manufacturer to procure raw
S-4/A
ew61 1zfe
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
t6acr02xtq58ogy
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
7mzhjioz
24 May 23
Business combination disclosure
7:05am
425
9l7oedq
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
s3l7z1ktda gv0j
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
10-K
mp7o883j6mj xpnx74o5
29 Mar 22
Annual report
7:36am
10-Q
5n1yyjqs8n7p5
15 Nov 21
Quarterly report
7:54am
424B4
e1b7pqb6dvw794uwc
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1
jhiyl0njt9
17 Sep 21
IPO registration
5:00pm